Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas

Despite improvement during the last ten years in the longevity of patients with metastatic clear cell renal cell carcinoma (mccRCC) the disease remains incurable. Hence, new therapeutic strategies are urgently needed. Relapse following anti-angiogenic treatment depends on the over-expression of vasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumond, Aurore, Montemagno, Christopher, Vial, Valérie, Grépin, Renaud, Pagès, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157203/
https://www.ncbi.nlm.nih.gov/pubmed/34067671
http://dx.doi.org/10.3390/cells10051222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157203/
https://www.ncbi.nlm.nih.gov/pubmed/34067671
http://dx.doi.org/10.3390/cells10051222

Ejemplares similares